Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.52 - $14.42 $3.79 Million - $21.7 Million
-1,503,195 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$12.69 - $20.72 $351,195 - $573,426
-27,675 Reduced 1.81%
1,503,195 $20.9 Million
Q4 2021

Feb 10, 2022

SELL
$19.7 - $23.71 $17,237 - $20,746
-875 Reduced 0.06%
1,530,870 $31.7 Million
Q3 2021

Nov 12, 2021

BUY
$21.32 - $29.36 $310,739 - $427,922
14,575 Added 0.96%
1,531,745 $34.1 Million
Q2 2021

Aug 12, 2021

BUY
$17.01 - $24.14 $9.68 Million - $13.7 Million
569,205 Added 60.04%
1,517,170 $35.9 Million
Q1 2021

May 13, 2021

BUY
$21.8 - $36.52 $4.46 Million - $7.47 Million
204,650 Added 27.53%
947,965 $22.8 Million
Q4 2020

Feb 12, 2021

BUY
$23.44 - $31.85 $6.01 Million - $8.17 Million
256,535 Added 52.7%
743,315 $20 Million
Q3 2020

Nov 13, 2020

BUY
$25.1 - $53.8 $12.2 Million - $26.2 Million
486,780 New
486,780 $14.1 Million

Others Institutions Holding VAPO

About VAPOTHERM INC


  • Ticker VAPO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,697,200
  • Market Cap $57.9M
  • Description
  • Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...
More about VAPO
Track This Portfolio

Track Champlain Investment Partners, LLC Portfolio

Follow Champlain Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.